Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate
Condition: Severe Malaria Interventions: Drug: Argesun 60mg (1 step parenteral artesunate); Drug: Artesun 60mg (2-step parenteral artesunate) Sponsors: University of Oxford; Shanghai Fosun Pharmaceutical Industrial Development Co, Ltd.; University of Kinshasa; National Institute for Medical Research, Tanzania Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials